Onychomycosis epidemiology and demographics: Difference between revisions
m (Changes made per Mahshid's request) |
|||
| Line 5: | Line 5: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The prevalence of onychomycosis is about 6-8% in the adult population.<ref>{{cite web |title=Impact 07 - Dermatology |url=http://www.baybio.org/pdf/IMPACT07_Derm.pdf |format=PDF |year=2007 |publisher=Bay Bio |accessdate=2007-06-13}}</ref> | The prevalence of onychomycosis is about 6-8% in the adult population.<ref>{{cite web |title=Impact 07 - Dermatology |url=http://www.baybio.org/pdf/IMPACT07_Derm.pdf |format=PDF |year=2007 |publisher=Bay Bio |accessdate=2007-06-13}}</ref>.The prevalence of onychomycosis in the United States is around 12%; and increases with increasing age. Approximately 90% of cases of toenail onychomycosis is caused by Trichophyton rubrum.<ref name="pmid24156160">{{cite journal| author=Scher RK, Rich P, Pariser D, Elewski B| title=The epidemiology, etiology, and pathophysiology of onychomycosis. | journal=Semin Cutan Med Surg | year= 2013 | volume= 32 | issue= 2 Suppl 1 | pages= S2-4 | pmid=24156160 | doi=10.12788/j.sder.0014 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24156160 }} </ref> | ||
Diabetics, patients infected with human immunodeficiency virus (HIV), patients with acquired immunodeficiency syndrome (AIDS), and patients with other types of immunosuppression (eg, transplant recipients and patients on long-term corticosteroid therapy) are at high risk.<ref name="pmid9425802">{{cite journal| author=Levy LA| title=Epidemiology of onychomycosis in special-risk populations. | journal=J Am Podiatr Med Assoc | year= 1997 | volume= 87 | issue= 12 | pages= 546-50 | pmid=9425802 | doi=10.7547/87507315-87-12-546 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9425802 }} </ref> | |||
==References== | ==References== | ||
Revision as of 09:48, 27 August 2021
|
Onychomycosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Onychomycosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Onychomycosis epidemiology and demographics |
|
Risk calculators and risk factors for Onychomycosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epidemiology and Demographics
The prevalence of onychomycosis is about 6-8% in the adult population.[1].The prevalence of onychomycosis in the United States is around 12%; and increases with increasing age. Approximately 90% of cases of toenail onychomycosis is caused by Trichophyton rubrum.[2]
Diabetics, patients infected with human immunodeficiency virus (HIV), patients with acquired immunodeficiency syndrome (AIDS), and patients with other types of immunosuppression (eg, transplant recipients and patients on long-term corticosteroid therapy) are at high risk.[3]
References
- ↑ "Impact 07 - Dermatology" (PDF). Bay Bio. 2007. Retrieved 2007-06-13.
- ↑ Scher RK, Rich P, Pariser D, Elewski B (2013). "The epidemiology, etiology, and pathophysiology of onychomycosis". Semin Cutan Med Surg. 32 (2 Suppl 1): S2–4. doi:10.12788/j.sder.0014. PMID 24156160.
- ↑ Levy LA (1997). "Epidemiology of onychomycosis in special-risk populations". J Am Podiatr Med Assoc. 87 (12): 546–50. doi:10.7547/87507315-87-12-546. PMID 9425802.